INTRODUCTION
============

Voltage-gated calcium (Ca~V~) channels play fundamental roles in mediating calcium influx upon depolarization ([@bib23]). They regulate many physiological responses ranging from neurotransmission to muscle contraction. Dysfunction in Ca~V~ channels is associated with many pathological conditions such as pain, epilepsy, migraine, and autism ([@bib8]). A Ca~V~ channel consists of three protein subunits, Ca~V~ α1, α2δ, and β ([@bib24]; [@bib7]). Ca~V~ α1 and α2δ subunits are transmembrane proteins responsible for forming the voltage-sensitive pore of the channel and promoting Ca~V~ α1 subunit stabilization at the plasma membrane, respectively. Ca~V~ β subunits are intracellular components that play an essential role in regulating gating properties and receptor modulation of Ca~V~ channels. The Ca~V~ β subunit sets the sensitivity of Ca~V~ channels to the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP~2~). Lipidation (palmitoylation) of the β subunit results in a plasma membrane localization and a decrease in current inactivation and PIP~2~ sensitivity of Ca~V~2.2 channels ([@bib26]; [@bib44]).

As Ca~V~ channels are critical in virtually all excitable cells, they are also intensely and dynamically modulated by an array of receptor-dependent signals. This includes regulation by G proteins after G protein--coupled receptor (GPCR) activation ([@bib52]). For the GPCRs coupled to pertussis toxin (PTX)--sensitive G~i/o~ protein, it is the Gβγ subunit that acts at the cytoplasmic surface of the membrane to bind directly to the Ca~V~2.2 α subunit after G~i/o~PCR activation, consequently inhibiting Ca~V~ current ([@bib21]; [@bib27]). This is the most extensively studied mechanism, characterized by its fast and membrane-delimited inhibition ([@bib4]), slowed activation kinetics, and a positive shift in the voltage dependence of the channel ([@bib2]; [@bib13]). This inhibition can be transiently relieved by large-step depolarizations that elicit dissociation of Gβγ from the channel ([@bib5]) and is thus also known as the voltage-dependent pathway ([@bib12]; [@bib11]). Contrastingly, a slow, voltage-independent inhibition occurs mostly through the activation of G~q~PCRs. In this case, the G~q~/PLC-mediated depletion of PIP~2~ and/or arachidonic acid generation is an important signaling messenger ([@bib51]; [@bib34]; [@bib17]; [@bib43]). However, it seems that, depending on the receptor type, the voltage dependency of channel suppression would be determined by different messengers and showed different shape of regulation (see review, [@bib46]; [@bib31]). Although G~i/o~PCRs are widespread in the presynaptic neurons, G~q~PCRs are known to inhibit Ca~V~2.2 in somata of sensory and sympathetic neurons ([@bib16]; [@bib18]; [@bib35]). Muscarinic acetylcholine receptor stimulation inhibits Ca~V~ channels through both of the described pathways ([@bib22]). M~2~ and M~4~ receptor subtypes are coupled to G~i/o~ and engage the voltage-dependent pathway to inhibit Ca~V~ channels, whereas the M~1~, M~3~, and M~5~ subtypes are coupled to G~q~ and modulate Ca~V~ channels through the voltage-independent, second-messenger pathway. However, the molecular mechanism underlying the latter G~q~PCR modulation has been questioned and needs further clarification.

Recent studies have developed and implemented useful techniques to further dissect the different modes of Ca~V~ channel modulation. Through the use of zebrafish voltage-sensitive phosphatase (Dr-VSP), reversible depletion of membrane PIP~2~ became possible by applying a large depolarizing pulse that activates the enzyme ([@bib39]; [@bib43]). This allows exclusive analysis of PIP~2~ depletion effects on channel modulation without any other production of second messengers or the activation of receptors ([@bib40]). Furthermore, genetically expressible inhibitors and real-time indicators have helped identify the molecular mechanisms by which inhibition of Ca~V~2.2 occurs after muscarinic receptor activation ([@bib32]; [@bib47]; [@bib28]).

Using these techniques, we continued our mechanistic study of G~q~ protein inhibition of N-type Ca~V~2.2 channels. In superior cervical ganglion (SCG) neurons of the rat, it has been established that Gα~q/11~/PLC activation and subsequent PIP~2~ hydrolysis produce the major voltage-independent regulation of Ca~V~2.2 channel after M~1~ muscarinic receptor activation; however, there also is some voltage-dependent regulation, raising the possibility of a role for Gβγ as well ([@bib29]; [@bib37]; [@bib17]; [@bib43]; [@bib49]). Also arguing for a second signaling pathway, [@bib44] found much less current inhibition after direct depletion of PIP~2~ through the use of Dr-VSP than was seen by activation of M~1~ muscarinic receptors. In the present study, we propose that inhibition of N-type Ca~V~ channels after G~q~PCR activation occurs not only through the familiar PIP~2~-dependent and voltage-independent pathway, but also through the phospholipid-independent, Gβγ-dependent pathway. Furthermore, we find that the relative predominance of these two pathways changes according to the Ca~V~ β subunit present.

MATERIALS AND METHODS
=====================

Cell culture and transfection
-----------------------------

Human embryonic kidney tsA-201 cells were maintained in DMEM supplemented with 10% FBS and 0.2% penicillin/streptomycin in 100-mm culture dishes. Subculture was accomplished every 7 d as cell density reached 75--80% using Ca^2+^-free DPBS for detaching and suspending the cells. For transfection, Lipofectamine 2000 (Invitrogen) was used when the confluency of cells reached 40--70%. In all experiments on Ca~V~ channels, cells were cotransfected with α1B, α2δ1, and various β subunits in a 1:1:1 molar ratio. Transfected cells were detached by trypsin and then moved onto poly-[l]{.smallcaps}-lysine--coated chips of coverslip 24 h after transfection, 12--24 h before the experiments. The cDNAs used were the channel subunits α1B of rat Ca~V~2.2e\[37b\], rat β3, and rat α2δ1 (from D. Lipscombe, Brown University, Providence, RI), rat β2a (from W.A. Catterall, University of Washington, Seattle, WA), chimeric rat β2a(C3,4S) (from J. Hurley, Indiana University, Bloomington, IN), rat β2a(C3,4S)-GFP (subcloned by D. Kim), chimeric Ca~V~2.2(α1C-1B) (from D. Yue, Johns Hopkins University, Baltimore, MD), Dr-VSP with IRES EGFP (from Y. Okamura, Osaka University, Osaka, Japan), human ECFP-PH(PLCδ1) and EYFP-PH(PLCδ1) (from K. Jalink, The Netherlands Cancer Institute, Amsterdam, Netherland), M~1~ muscarinic receptor (from N. Nathanson, University of Washington), human M~2~ muscarinic receptor (from Guthrie Resource Center, Rolla, MO), and C terminus of β-adrenergic receptor kinase (βARK-ct; from R. Lefkowitz, Duke University, Durham, NC).

Current recording
-----------------

The whole-cell configuration was used to record currents carried by Ba^2+^ in transfected tsA-201 cells using patch clamp amplifier EPC-9 or EPC-10 USB (HEKA) at room temperature (22--25°C). Pipette resistance was 1--4 MΩ, and a series resistance of 2--6 MΩ was compensated by 60%. Ba^2+^ currents were measured with p/5 subtraction with a membrane holding potential of −80 mV, followed by 10-ms step depolarization to 10 mV. For full experiments, voltage pulses were repeated every 2 or 4 s. Application of step depolarization to 120 mV for 1 s induced full activation of Dr-VSP. A conditioning depolarizing prepulse was used to test the involvement of Gβγ.

Förster resonance energy transfer (FRET)
----------------------------------------

Regular pulses of indigo light (438 ± 12 nm) from a monochromator (Polychrome V; TILL Photonics) excited the fluorescent proteins. Emission, which passed through a 40×, NA 0.95 dry immersion objective lens (Olympus), was separated into short (460--500 nm) and long (520--550 nm) wavelengths by appropriate filters and then acquired by two photomultipliers. Donor and acceptor signals obtained by photometry (TILL Photonics) were transferred to the data acquisition board (PCI-6221; National Instruments). Signal acquisition and real-time calculation of FRET ratio were conducted by a homemade program. To correct bleed-through of emission of CFP into the YFP detector, cells expressing only CFP were used to obtain the ratio of the detected signal in short and long wavelength emission channels ([@bib28]). The calculated ratio (cFactor = CFP/YFP = 0.55) was used to correct the raw YFP emission signal. The bleed-through of YFP light into the CFP detector was only 0.02 and was neglected. The FRET ratio was thus calculated as follows:$$\text{FRETr} = \left( {\text{YFP}_{\text{C}} - \text{cFactor} \times \text{CFP}_{\text{C}}} \right)\text{/CFP}_{\text{C}},$$where YFP~C~ is the signal from YFP excited as result of FRET (YFP emission by CFP excitation), CFP~C~ is CFP emission detected by the short wavelength photomultiplier, and YFP~C~ is YFP emission detected by long wavelength photomultiplier.

Confocal imaging
----------------

TsA-201 cells were transfected on poly-[l]{.smallcaps}-lysine--coated coverslips and imaged within the next 24--48 h. The bath solution contained 160 mM NaCl, 2.5 mM KCl, 2 mM CaCl~2~, 1 mM MgCl~2~, 10 mM HEPES, and 8 mM glucose adjusted to pH 7.4 with NaOH. Images were taken with a confocal microscope (LSM 700; Carl Zeiss) at room temperature every 5 s and processed with ZEN 2009 Light Edition (Carl Zeiss) and Igor Pro (WaveMetrics).

Solutions and materials
-----------------------

The bath solution used for recording Ba^2+^ current contained 150 mM NaCl, 10 mM BaCl~2~-2H~2~O, 1 mM MgCl~2~, 10 mM HEPES, and 8 mM glucose and was titrated to pH 7.4 with NaOH. The pipette solution contained 160 mM CsCl, 5 mM MgCl~2~, 5 mM HEPES, 0.1 mM 1,2-bis(2-aminophenoxy)ethane *N*,*N*,*N*′*N*′-tetraacetic acid (BAPTA), 3 mM Na~2~ATP, and 0.1 mM Na~3~GTP and was titrated to pH 7.4 with CsOH. Reagents used were oxotremorine-M (Oxo-M; Research Biochemicals); BAPTA, DMEM, FBS, Lipofectamine 2000, and penicillin/streptomycin (Invitrogen); and ATP, GTP, and other chemicals (Sigma-Aldrich).

Data analysis
-------------

Pulse/Pulse Fit 8.11 software and the patch clamp amplifier (HEKA) were used for data acquisition and analysis. Supplementary data processing used Excel (Microsoft) and Igor Pro. Exponential fits were used to measure the time constants. All quantitative data were expressed as the mean ± SEM. Comparison between two groups was analyzed using the Student's *t* test, and differences were considered significant at the P \< 0.05 level. Comparison among more than two groups was analyzed using one-way ANOVA followed by a post hoc test.

RESULTS
=======

M~1~ muscarinic receptors may suppress N-type Ca~V~2.2 through two modulatory pathways
--------------------------------------------------------------------------------------

To dissect pathways by which Ca~V~2.2 channels are modulated by muscarinic receptor activation, tsA-201 cells were transfected with Ca~V~ subunits α1B, α2δ1, and β3 and either M~1~ or M~2~ receptors. Barium currents were evoked by depolarizing voltage steps. Perfusion of the muscarinic agonist Oxo-M inhibited the current by 68 ± 3% for M~1~R and by 72 ± 5% for M~2~R ([Fig. 1 A](#fig1){ref-type="fig"}). The differential modulatory pathways of these receptors were first isolated with the use of PTX, which inactivates G~i/o~ by ADP ribosylation. As expected, preincubation in PTX (300 ng/ml, 12 h) strongly reduced Oxo-M--mediated current inhibition in cells expressing the G~i/o~-coupled M~2~R (9 ± 2%; [Fig. 1 A](#fig1){ref-type="fig"}, right). Denatured PTX did not reduce the current. Furthermore, coexpressing βARK-ct, which chelates free Gβγ subunits, prevented Ca~V~2.2 current inhibition in a manner similar to PTX ([@bib32]). These experiments confirmed that the primary mechanism by which M~2~R inhibits Ca~V~2.2 is through Gβγ subunits released after activation of G~i/o~ ([Fig. 1 C](#fig1){ref-type="fig"}, bottom).

![Differential modulation of Ca~V~2.2 channels by muscarinic receptors depends on the Ca~V~ β subunit. (A and B) Cells transfected with α1B (Ca~V~2.2), α2δ1, and β3 (A) or β2a (B) subunits were cultured in the presence or absence of PTX or heat-inactivated PTX (*i*PTX) for 12 h. The cells were stimulated with 10 µM Oxo-M to activate muscarinic receptors or depolarized to 120 mV for 1 s to activate the coexpressed Dr-VSP. (A) Ca~V~2.2 currents before and after the stimulation of M~1~ (left) and M~2~ (right) muscarinic receptors or the activation of Dr-VSP were measured in cells expressing β3, and the currents were superimposed. Blue traces are the control, and black traces are after stimulation. Current regulation by M~2~ receptor was also measured in cells cotransfected with βARK-ct. (bottom) Summary of current inhibition (percentage) by the activation of muscarinic receptors or Dr-VSP. Dots indicate the individual data points for each experiment (*n* = 5--15). Analysis was performed by one-way ANOVA followed by a post hoc test. (B) Ca~V~2.2 currents were measured before and after the stimulation in cells expressing β2a. (bottom) Summary of current inhibition (percentage) by the activation of M~1~ receptor or Dr-VSP. (A and B) Mean ± SEM is shown. \*, P \< 0.01, compared with current inhibition by Oxo-M. (C) Diagram of inhibitory signaling to Ca~V~2.2 channels by M~1~ and M~2~ muscarinic receptors. VD, voltage-dependent inhibition; VI, voltage-independent inhibition.](JGP_201411245_Fig1){#fig1}

In contrast, the G~q~PCR M~1~R is thought to inhibit Ca~V~2.2 mainly via PLC and depletion of PIP~2~ ([Fig. 1 C](#fig1){ref-type="fig"}, top; [@bib17]; [@bib43]; [@bib49]). Preincubation with PTX did not change the inhibition of current by M~1~ muscarinic receptor stimulation ([Fig. 1](#fig1){ref-type="fig"}, A \[left\] and B). Thus M~1~R function does not involve G~i/o~. The PIP~2~-dependent pathway can be studied in isolation using activation of the voltage-sensitive lipid phosphatase Dr-VSP, which can deplete PIP~2~ from the plasma membrane quickly during a strong depolarizing pulse. The cotransfected Dr-VSP showed different extents of Ca~V~2.2 current inhibition depending on the type of Ca~V~ β subunit used, as reported in our previous study ([@bib44]). Depolarization with the expressed Dr-VSP inhibited current more strongly in cells cotransfected with β3 subunits ([Fig. 1 A](#fig1){ref-type="fig"}, left) than in those cotransfected with β2a subunits ([Fig. 1 B](#fig1){ref-type="fig"}). Such observations led to the main hypothesis of this study: if Dr-VSP depletes PIP~2~ from the membrane yet sometimes leads to only weak current inhibition through this phospholipid-dependent pathway, other signals must contribute to the remaining significant portion of current inhibition by M~1~ muscarinic stimulation. A summary of the known signaling pathways is given in [Fig. 1 C](#fig1){ref-type="fig"}, with a question mark designating this presumed additional pathway from M~1~Rs.

Gβγ scavenger attenuates M~1~ muscarinic receptor--induced Ca~V~2.2 current inhibition
--------------------------------------------------------------------------------------

A series of studies was performed to determine whether Gβγ subunits might play a role in Ca~V~2.2 modulation by M~1~ muscarinic receptor. Several results were consistent with this hypothesis, but as we eventually show, the outcomes depended on which Ca~V~ β subunit was used. [Fig. 2 A](#fig2){ref-type="fig"} compares Ca~V~2.2 (β2a) current inhibition in control cells with that in cells expressing the Gβγ scavenger βARK-ct. The scavenger attenuates inhibition strongly, as if Gβγ is needed for the M~1~ muscarinic inhibition, when the Ca~V~ β2a channel subunit is present. There are additional hallmarks of inhibition by Gβγ subunits. The voltage-dependent activation curves showed a shift to the right by ∼5 mV during the M~1~ receptor activation ([Fig. 2 B](#fig2){ref-type="fig"}). Furthermore, comparison of single traces of current recorded before and after Oxo-M treatment also revealed differences in the activation kinetics of control cells but not in cells expressing βARK-ct ([Fig. 2 C](#fig2){ref-type="fig"}). The control cells transfected with α1B and β2a subunits displayed slowing of activation during Oxo-M (also see [Fig. 2 D](#fig2){ref-type="fig"}, left), whereas cells cotransfected with βARK-ct showed little change of activation. This observation makes it seem as if the inhibition of Ca~V~2.2 (β2a) by Oxo-M involves Gβγ. In contrast, for cells expressing β3 subunits, the Gβγ hallmark changes in current activation were much less prominent ([Fig. 2 D](#fig2){ref-type="fig"}, right).

![βARK-ct attenuates M~1~ muscarinic receptor--induced inhibition of Ca~V~2.2(β2a) currents. (A) Cells transfected with Ca~V~2.2, α2δ1, and β2a in the presence and absence of βARK-ct were stimulated with Oxo-M, and the Ca~V~2.2(β2a) current suppression was measured. (B) Voltage dependence of activation of the Ca~V~2.2(β2a) channel before and during M~1~ receptor stimulation with Oxo-M. Dashed line is the I-V relation during Oxo-M application, which is scaled to the peak amplitude of the control. (C) Superimposed Ca~V~2.2(β2a) current traces a and b from A. In control, the b′ dashed trace is a scaled version of b. (D) Superimposed Ca~V~2.2(β2a) and Ca~V~2.2(β3) current traces for control and during the stimulation of M~1~ receptor. Blue line in right panel shows the scaled trace of Ca~V~2.2(β3) current after Oxo-M application (red). Note that during the Oxo-M application, activation of Ca~V~2.2(β2a) channels (left) but not Ca~V~2.2(β3) channels (right) is dramatically slowed.](JGP_201411245_Fig2){#fig2}

We next tested the effects of Gβγ on channel inhibition by depleting PIP~2~ by means of Dr-VSP ([@bib40]), which is appropriate for experimental designs involving reversible PIP~2~ depletion after an activating depolarization. The standardized voltage protocol to deplete PIP~2~ from the membrane by activating Dr-VSP was applied to cells expressing βARK-ct ([Fig. 3 A](#fig3){ref-type="fig"}, top). Compared with control cells, the expression of βARK-ct did not diminish the current inhibition mediated by Dr-VSP ([Fig. 3 A](#fig3){ref-type="fig"}). Thus, we conclude that βARK-ct does not impede the PIP~2~-dependent pathway of Ca~V~2.2 (β2a) inhibition, but it does block the Gβγ-dependent pathway. As is summarized in [Fig. 3 B](#fig3){ref-type="fig"}, M~1~ muscarinic current inhibition in β2a-expressing cells is significantly decreased by coexpressing βARK-ct, again as if Gβγ plays an important role in Ca~V~2.2 (β2a) modulation. In contrast, the smaller current inhibition upon activation of Dr-VSP was not changed by coexpressing βARK-ct. This suggests that the M~1~R-induced inhibition of Ca~V~2.2 (β2a) could involve a direct action of Gβγ on the channel itself rather than an action through the phospholipid-sensitive pathway.

![Differential effects of βARK-ct on M~1~R- and Dr-VSP--induced inhibition of Ca~V~2.2(β2a) currents. (A) Ca~V~2.2(β2a) current inhibition by Dr-VSP activation in control or cells expressing βARK-ct. Cells received a 10-ms test pulse (a) and then a 1-s depolarization to 120 mV for activating the expressed VSP, followed by the second 10-ms test pulse (b). Note that current inhibition by Dr-VSP activation was not significantly different between control and βARK-ct--expressing cells. (B) Summary of the current inhibition (percentage) after the activation of M~1~ receptors ([Fig. 2 A](#fig2){ref-type="fig"}) or Dr-VSP in control and βARK-ct--expressing cells. Data are mean ± SEM (*n* = 5--7).](JGP_201411245_Fig3){#fig3}

Single-cell assay reveals separation of fast and slow pathways in M~1~R-induced current modulation
--------------------------------------------------------------------------------------------------

We simultaneously measured the current modulation and PIP~2~ hydrolysis in single control and βARK-ct--expressing cells. Plasma membrane PIP~2~ was measured by FRET between CFP- and YFP-labeled probes that selectively bind to membrane PIP~2~ ([@bib47]; [@bib28]; [@bib43]; [@bib14]). A decrease of their FRET interaction indicates depletion of PIP~2~ that releases the probe from the membrane. [Fig. 4 A](#fig4){ref-type="fig"} plots representative time courses of Ca~V~2.2 current and the FRETr change in single control and βARK-ct--expressing cells. After perfusion of Oxo-M, the decrease of FRETr (blue trace) was comparable in the two cells, whereas the current inhibition (red trace) showed several differences. On average, current inhibition was 46 ± 4% in control cells (*n* = 7) and only 25 ± 5% in βARK-ct--expressing cells (*n* = 6; [Fig. 4 C](#fig4){ref-type="fig"}). Furthermore, the latency for initiation of current inhibition was less than that for the FRETr decrease ([Fig. 4](#fig4){ref-type="fig"}, A \[right\] and B). The mean lag time between the initiation of Ca~V~ current inhibition and PIP~2~ hydrolysis was 4.1 ± 0.6 s in control cells and 0.7 ± 0.3 s in βARK-ct--expressing cells ([Fig. 4 D](#fig4){ref-type="fig"}). The variability of fluorescent protein expression was compensated by normalizing the FRET change between 0 and 1 and averaging the traces ([Fig. 4 B](#fig4){ref-type="fig"}). As expected, the time constant of FRET change (PIP~2~ hydrolysis) was not affected by βARK-ct ([Fig. 4 E](#fig4){ref-type="fig"}, τ = 8.7 ± 1.5 s for control and τ = 8.9 ± 1.1 s for βARK-ct--expressing cells). [Fig. 5](#fig5){ref-type="fig"} summarizes the main results of [Fig. 4](#fig4){ref-type="fig"}. First, we estimated a putative component of current inhibition by G protein βγ subunits by subtracting the averaged current of the two groups ([Fig. 5 A](#fig5){ref-type="fig"}, dashed green line). Then we mimicked the observed time courses with exponential curves [Fig. 5 B](#fig5){ref-type="fig"}. This model showed that, as would be appropriate for direct G protein action, the difference component is fast with an exponential time constant of 1.6 s ([Fig. 5 B](#fig5){ref-type="fig"}, dashed green line). The remaining component, attributed to PIP~2~ signaling, has a slow time course like the FRETr change.

![Simultaneous measurement of current inhibition and PIP~2~ hydrolysis in single cells. All cells coexpressed Ca~V~2.2(β2a) channel subunits, PH domain probes, and M~1~ receptors. (A) Ca~V~2.2(β2a) current and PIP~2~ (FRET ratio, FRETr) were measured simultaneously in single cells in the absence (top) or presence (bottom) of βARK-ct. 10 µM Oxo-M was applied during solid bars. (right) Scaled responses from the dashed boxes shown in the left panels. The initiation of the muscarinic response is indicated by arrows. (B) Normalized mean time courses of current suppression and PIP~2~ hydrolysis (FRETr) from single cells without or with βARK-ct expression. (C) Summary of maximum current inhibition by Oxo-M in control and cells expressing βARK-ct. \*\*, P \< 0.01, compared with control. (D) Effect of βARK-ct on lag time between the initiation of current inhibition and the FRETr change. \*\*\*, P \< 0.001. (B--D) Data are mean ± SEM. (E) Analysis of the onset time (τ) for current inhibition and PIP~2~ hydrolysis (FRETr) in control and βARK-ct--expressing cells. Data are mean ± SEM (*n* = 6--7). \*\*, P \< 0.01.](JGP_201411245_Fig4){#fig4}

![Kinetic assays reveal participation of Gβγ in M~1~ receptor--induced Ca~V~2.2(β2a) current inhibition. (A) Summary of [Fig. 4 B](#fig4){ref-type="fig"}. The estimated effect of M~1~R-mediated release of Gβγ on Ca~V~2.2 current (ΔCa~V~2.2, green) was calculated by subtracting the mean current of βARK-ct (orange) from that of control (red). Blue trace indicates M~1~R-induced PIP~2~ hydrolysis observed by FRET change. (B) Interpretation of the Ca~V~2.2 current inhibition as a series of exponential curves in control and βARK-ct--expressing cells. I~control~ = exp(−t/4.05) (t \> 0; red), I~βARK-ct~ = 0.52\*exp(−(t − 4)/4.87) (t \> 4; orange), FRET~r~ = exp(−(t − 4)/8.78) (t \> 4; blue). Predicted Gβγ-induced Ca~V~ current inhibition (dashed green) was calculated by subtracting the mean current of βARK-ct from that of control. The amplitude of I~βARK-ct~ is determined by obtaining the relative current amplitude between control and βARK-ct--expressing cells.](JGP_201411245_Fig5){#fig5}

Gβγ-dependent, but not PIP~2~-dependent, modulation is absent in a chimeric N-type channel
------------------------------------------------------------------------------------------

The effects of Gβγ on Ca~V~2.2 regulation were investigated through a more direct approach. We used a mutated Ca~V~2.2 α subunit that does not bind Gβγ subunits. In this chimera, called Ca~V~2.2 α1C-1B, the N terminus of the Ca~V~2.2(α1B) subunit was replaced by the N terminus of the Ca~V~1.2(α1C) subunit, which lacks the N-terminal Gβγ-binding site of α1B ([@bib1]). [Fig. 6 A](#fig6){ref-type="fig"} illustrates the modulation of N-type currents in cells expressing this α1 construct with β2a upon activation of either M~2~R or M~1~R receptors. The chimera shows a smaller response to either receptor, as is summarized in [Fig. 6 C](#fig6){ref-type="fig"}. The M~2~R, a G~i/o~PCR, is anticipated to signal through the direct binding of Gβγ, so the chimera should lack modulation, exactly as seen. Inhibition dropped from 60 to 2%. However, now we find that signaling from the M~1~R, a G~q~PCR, is also decreased by the chimera, giving only ∼10% inhibition of current instead of the \>40% seen in control cells ([Fig. 1 B](#fig1){ref-type="fig"}), consistent with the concept that M~1~Rs also can signal by the Gβγ pathway. Continuing on, as expected, Ca~V~2.2(α1C-1B) (β2a) current inhibition by activation of Dr-VSP was not changed compared with control conditions ([Fig. 6, B and C](#fig6){ref-type="fig"}).

![Voltage-dependent muscarinic modulation disappears in Gβγ-insensitive chimeric Ca~V~2.2(α1C-1B) channels. (A) Effects on Ca~V~2.2(α1C-1B) (β2a) currents of M~1~ and M~2~ muscarinic receptor stimulation. The current amplitude was measured at 10 mV every 4 s. Insets show currents a and b superimposed. (B) Inhibition by Dr-VSP activation of Ca~V~2.2(α1C-1B) (β2a) currents. Cells received a test pulse (a) and then were depolarized to 120 mV for 1 s, followed by a second test pulse (b). Current traces before and after the Dr-VSP activation in cells expressing the α1C-1B and β3 subunits are shown. (C) Summary of current suppression by muscarinic stimulation or Dr-VSP activation. (D) Current traces before (a) and during (b) the Oxo-M application (left and middle) or Dr-VSP activation (right) in cells expressing the α1C-1B and β3 subunits. Effects on Ca~V~2.2(α1C-1B) (β3) currents of M~1~ and M~2~ muscarinic receptor stimulation and Dr-VSP activation were traced as above. (E) Summary of current suppression by muscarinic stimulation or Dr-VSP activation. (C and E) Data are mean ± SEM (*n* = 5 for each bar).](JGP_201411245_Fig6){#fig6}

We now consider whether switching from the Ca~V~ β2a subunit to the Ca~V~ β3 subunit alters the modulation of the Ca~V~2.2(α1C-1B) chimera. Qualitatively, the modulation had similar features with either β subunit ([Fig. 6 D](#fig6){ref-type="fig"}). As expected, activation of M~2~R, which acts primarily through the Gβγ pathway, produced very little inhibition ([Fig. 6 E](#fig6){ref-type="fig"}). However, interestingly, with the Ca~V~ β3 subunit, the inhibition upon activation of M~1~ muscarinic receptors or upon PIP~2~ depletion by VSP was much higher than with β2a-containing chimeric channels. Indeed it was more like the inhibition of wild-type Ca~V~2.2 channels. This fits well with the concept that M~1~ muscarinic inhibition of Ca~V~2.2 channels with β3 is voltage independent and does not need Gβγ subunits.

M~1~R-induced, voltage-dependent modulation of Ca~V~2.2 currents is dependent on Ca~V~ β subtypes
-------------------------------------------------------------------------------------------------

Our results reveal that M~1~Rs use two pathways to suppress Ca~V~2.2 currents. We now examine further whether the choice between inhibitory pathways might depend on the Ca~V~ channel β subunit. [Fig. 7 A](#fig7){ref-type="fig"} shows that different β subunits localize differently. Expressed by themselves, β2a subunits are membrane localized and β2b and β3 subunits are soluble in the cytosol ([Fig. 7 A](#fig7){ref-type="fig"}). Palmitoylation on two consecutive N-terminal cysteines makes β2a subunits membrane resident ([@bib9]; [@bib26]), and when the cysteines are substituted by serines, the mutant β2a(C3,4S) moves to the cytosol. Appending a membrane-targeting Lyn sequence to β3 makes the chimeric Lyn-β3 subunit localize at the plasma membrane ([@bib44]).

![Cytosolic β subunit decreases the Gβγ-mediated, voltage-dependent suppression of Ca~V~2.2 currents. (A) N-terminal amino acid sequences of β2a, β2a(C3,4S), β2b, and β3 subunit with GFP as a fluorescent label. In the palmitoylation-resistant mutant β2a(C3,4S), both palmitoylated cysteine residues (\*, blue) are replaced with serine (red). Lyn-β3 is labeled with YFP. (bottom) Confocal images of the β subunits expressed in tsA-201 cells. (B) Inhibition of Ca~V~2.2 current by M~1~ receptors is significantly relieved by a prepulse (+PP) in cells with membrane-localized β subunits but not in cells with cytosolic β subunits. Cells were given a test pulse (−PP) and then depolarized to 130 mV for 20 ms, followed by the second test pulse after 20 ms (+PP). The experiments were performed before (control) and during the Oxo-M application (+Oxo-M). (bottom) Summary of the prepulse experiments in control and Oxo-M--perfused cells with different Ca~V~ β subunits. The current amplitude after Oxo-M application is given as percentage of the initial control. Data are mean ± SEM (*n* = 5--6). \*, P \< 0.01.](JGP_201411245_Fig7){#fig7}

Using the Gβγ-resistant chimera Ca~V~2.2(α1C-α1B), we saw that coexpression with β2a makes channels that are more sensitive to the Gβγ-dependent pathway and less sensitive to the PIP~2~-dependent pathway, whereas coexpression with β3 makes channels more sensitive to the PIP~2~-dependent pathway relative to the Gβγ-dependent pathway. The same switch applies to wild-type Ca~V~2.2 channels. Using diverse β constructs, we further analyzed the voltage-dependent and -independent modulation of Ca~V~2.2 currents by M~1~ muscarinic receptors. By applying a prepulse of 130 mV (in the absence of VSP), the Gβγ-dependent portion of inhibition upon Oxo-M treatment could be estimated ([Fig. 7 B](#fig7){ref-type="fig"}). M~1~R activation before the prepulse gave rise to the expected inhibition percentage as in [Fig. 1 A](#fig1){ref-type="fig"}. However, after the prepulse, the inhibition percentage upon Oxo-M perfusion was much reduced in β2a expressing cells, ∼40 to ∼10%, and only slightly reduced in β2b-, β3-, and β2a(C3,4S)-expressing cells ([Fig. 7 B](#fig7){ref-type="fig"}). Thus, the voltage-dependent inhibition of Ca~V~2.2 depends on the subcellular location of the β subunits and is stronger in channels with membrane-binding β subunits. The voltage-independent inhibition is stronger in channels with cytosolic β subunits.

The PIP~2~-dependent portion of inhibition was tested in cells with different β subunits ([Fig. 8 A](#fig8){ref-type="fig"}) using the potent PIP~2~ 5-phosphatase Dr-VSP. Cells transfected with Ca~V~2.2, various β subunits, and Dr-VSP were depolarized to 120 mV for 1 s. The PIP~2~ depletion--dependent inhibition of current was low at 10% with β2a compared with 40--60% with cytosolic β2b, β3, and β2a(C3,4S). When membrane-targeted Lyn-β3 was expressed, the PIP~2~ sensitivity decreased to ∼20% ([Fig. 8 B](#fig8){ref-type="fig"}). [Fig. 8 B](#fig8){ref-type="fig"} contrasts the inhibition percentages of PIP~2~-dependent, voltage-independent and Gβγ-mediated, voltage-dependent pathways. Though M~1~ receptor stimulation suppresses all combinations of Ca~V~2.2 and β subunits, depending on the types of Ca~V~ β subunit, the modulatory mechanism by M~1~ receptor is clearly different.

![Cytosolic β subunit increases the PIP~2~ depletion--mediated suppression of Ca~V~2.2 currents. (A) Current inhibition by Dr-VSP activation in cells expressing different β subunits. Cells received a test pulse (a) and then were depolarized to 120 mV for 1 s, followed by the second test pulse (b). The a and b currents are superimposed. (B) Summary of the Dr-VSP--induced inhibition of Ca~V~2.2 current. Data are mean ± SEM (*n* = 6--8). (C) Differential effects (mean percent inhibition) of Dr-VSP-induced, voltage-independent (A) and Gβγ-mediated, voltage-dependent ([Fig. 7 B](#fig7){ref-type="fig"}) pathways on the Oxo-M suppression of Ca~V~2.2 channels with different Ca~V~ β subunits. Mean maximal inhibition by M~1~ receptor activation is presented in the top.](JGP_201411245_Fig8){#fig8}

DISCUSSION
==========

We have shown that with an appropriate choice of Ca~V~ β subunit, a G~q~PCR can signal by Gβγ subunits to suppress N-type Ca^2+^ currents. This contrasts with the simpler view that PTX-insensitive, G~q~PCRs modulate Ca^2+^ channels exclusively by actions downstream of PLC and that only PTX-sensitive G~i/o~PCRs can modulate through Gβγ, and it extends earlier clear suggestions of Gβγ roles in M~1~R signaling ([@bib29]; [@bib37]; [@bib17]; [@bib43]; [@bib49]). Our adjusted working hypothesis is summarized as a flow chart in [Fig. 9 A](#fig9){ref-type="fig"}. M~1~Rs inhibit Ca~V~2.2 not only through Gα~q~ and PLC but also through the Gβγ pathway, whereas M~2~Rs suppress principally through the Gβγ pathway. Furthermore, for M~1~Rs, the choice between PLC and Gβγ pathways is biased by the subtype of Ca~V~ β subunit expressed. Channels with the membrane--lipid-interacting β subunit β2a were more sensitive to the Gβγ-dependent pathway and less to the PIP~2~ depletion, whereas channels with cytosolic β subunits, including β2b, β3, and β2a(C3,4S), were more sensitive to PIP~2~ depletion ([Fig. 9 B](#fig9){ref-type="fig"}). Our data also showed that even though the maximum inhibition of N-type Ca~V~ current by M~1~ receptors ranged from 40 to 65% for different cytosolic Ca~V~ β subunits, the relative proportion of the total inhibition mediated by PIP~2~ and Gβγ was almost the same for each of the cytosolic β subtypes. For M~1~ muscarinic inhibition with cytosolic β subunits, the fractional distribution between the Gβγ-dependent pathway and the PIP~2~-dependent pathway was ∼20 and ∼80% of the total ([Fig. 9 B](#fig9){ref-type="fig"}). In contrast, in cells expressing the membrane-localized β2a subunits, the fractional distribution was reversed, ∼80 and ∼20%, and in cells expressing the membrane-targeted form of β3, Lyn-β3, the distribution was equal, ∼50 and 50%. This intermediate effect of Lyn-β3 is consistent with its weaker effects on current inactivation and on PIP~2~ depletion--mediated suppression compared with control β3 ([@bib44]).

![M~1~R suppresses Ca~V~2.2 currents through two separate pathways. (A) Diagram shows two separate signaling pathways independently modulating Ca~V~2.2 channels. The predominance of each type of modulation is controlled by the β subunit. Solid lines indicate major inhibitory pathways. Dashed lines indicate minor or weak inhibitory pathways. (B) Relative effects of PIP~2~- and Gβγ-dependent pathways on the Oxo-M regulation of Ca~V~2.2 channels with different β subunits. Membrane localization of β subunits decreases the PIP~2~-dependent regulation, whereas it enhances the effects of Gβγ subunit--mediated, voltage-dependent regulation.](JGP_201411245_Fig9){#fig9}

Several of our findings support Gβγ as one of the inhibitory signals in M~1~ muscarinic suppression of Ca~V~2.2 channels. (a) M~1~ receptor activation shifts the voltage dependence of activation of channels rightward by ∼5 mV and slows the activation kinetics, comparable with Gβγ-dependent regulation of N-type channels in sympathetic neurons ([@bib13]; [@bib3]; [@bib5]). (b) Coexpression of the Gβγ chelator reduced inhibition of the Ca^2+^ currents by M~1~R stimulation ([@bib29]; [@bib37]). (c) M~1~ receptor activation induces a fast component of channel inhibition in addition to a slow one ([@bib37]). The fast, βARK-ct--sensitive component precedes the slow one by 3 s, about the time difference between G~q~ activation and PIP~2~ depletion ([@bib28]). (d) A chimeric α1 calcium channel subunit unable to bind to Gβγ showed much less M~1~ receptor--induced inhibition. Lastly (e), the suppression of Ca~V~2.2 current by M~1~Rs could be reversed partially by applying a strong positive prepulse. Thus, for M~1~R signaling, a Gβγ-mediated, voltage-dependent pathway coexists with the well-known slow PLC and PIP~2~-sensitive voltage-independent pathway that is not affected by the expression of βARK-ct, chimeric α1 subunits, or depolarizing prepulses ([Fig. 6 A](#fig6){ref-type="fig"}; [@bib37]; [@bib17]; [@bib43]). With M~1~Rs, neither pathway is sensitive to PTX.

Our single-cell experiments combining FRET and patch clamp confirmed that M~1~ receptors can suppress the N-type current through the fast Gβγ-mediated signaling pathways and that the fast current inhibition is independent from and unable to be triggered by the slow PIP~2~ depletion. Many previous studies suggested that N-type channel suppression by G~q~PCRs occurs through both fast and slow pathways ([@bib22]; [@bib37]; [@bib38]). Here, we clearly show that the M~1~ receptor--mediated channel inhibition and the PIP~2~ depletion are temporally separated (a lag time) in a live single cell. Current inhibition begins earlier than PIP~2~ depletion, and the lag time was almost completely abolished by the Gβγ scavenger βARK-ct, resulting in almost the same time constants for the PIP~2~ depletion and the current inhibition. This temporal separation can be interpreted as a Gβγ-dependent Ca~V~ current inhibition that occurs immediately after the receptor stimulation in synapse, followed by a PLC- and lipid-dependent slow current inhibition, if the receptor activation lasts longer than the lag time. Hence the lag time determines a threshold for diversity of signaling in synaptic transmission. For example, short (\<2 s) M~1~ receptor stimulation may suppress the Ca~V~ currents only through the fast inhibitory pathway, whereas longer receptor stimulation may regulate slower signaling by PIP~2~ depletion, PKC activation, Ca^2+^ release from the ER, and gene expression by activating the downstream PLC signaling. Thus, our new finding would provide clues to elucidate the role of M~1~R and Ca~V~ channels in synaptic plasticity such as Gα~q~-mediated long-term depression ([@bib30]; [@bib10]).

Ca~V~ β subunit isoforms have profound effects on calcium channel trafficking, inactivation kinetics, and susceptibility to modulation. A key distinction governing the actions of isoforms is whether they are palmitoylated and membrane directed (β2a, Lyn-β3) or not (β2a(C3,4S), β2b, β3; [Fig. 9](#fig9){ref-type="fig"}; [@bib9]; [@bib26]; [@bib15]). Thus, [@bib15] showed that raising free Gβγ by transient expression of Gβ subunits induced kinetic slowing of activation in Ca~V~2.2 channels expressed with lipidated β2a subunit, whereas it had little effect in channels with other types of Ca~V~ β subunit. Similarly, in our experiments, expression of β2a gave a stronger Gβγ-mediated, voltage-dependent inhibition, whereas expression of β3 gave a stronger PIP~2~-mediated, voltage-independent regulation. The dependence on subcellular localization was confirmed by reversing the targeting of the β2a and β3 subunits. A cytosolic β subunit conferred reduced voltage dependency and increased voltage independency of the M~1~ muscarinic inhibition of N-type calcium channels. So far, the mechanism of how the membrane-targeted Ca~V~ β subunit regulates the Gβγ signaling to Ca~V~2.2 channel is not clear. However, it is well known that the intracellular I-II loop (as well as N and C termini) of the α1 subunit is the major target site for both Gβγ and Ca~V~ β subunits, and thus binding of Ca~V~ β2a to the I-II loop through the BID domain and the plasma membrane through N-terminal palmitoyl groups at the same time may affect the mobility of this region in an unfavorable way, making the Ca~V~ channel retain high Gβγ binding affinity and be more susceptible to βγ subunit--mediated inhibition ([@bib52]).

Our findings are important to understand regulation of Ca^2+^ channels by neurotransmitter receptors that couple to G~q~ in excitable cells. Previous studies reported that the lipidated β2a subunit is highly expressed in chromaffin cells, form noninactivating N-type channel currents, and contribute to hormone release ([@bib6]). The β2a subunit is also expressed broadly in brain, heart, and aorta ([@bib25]; [@bib41]), though only a small proportion of endogenous Ca~V~2.2 interacts with the β2a subunit ([@bib42]). SCG neurons express mostly β2a subunits but also β3 and β4 ([@bib20]), accounting for relatively slow N-type current inactivation and less sensitivity to Dr-VSP--mediated PIP~2~ depletion compared with expression systems with the β3 subunit alone ([@bib44]). However, [@bib17] and [@bib49] clearly showed that the N-type Ca^2+^ current was still strongly suppressed by membrane PIP~2~ depletion in neurons, suggesting that a disproportionate fraction of β3 subunits become bound to N-type α1B subunits. This is supported by previous studies showing that the modulation of N-type currents by M~1~ receptors in SCG neurons appears as a mixture of voltage-dependent and -independent pathways ([@bib29]; [@bib43]) and that β3 subunits are the predominant form associated with brain N-type Ca^2+^ channels ([@bib48]). Furthermore, the temporal expression pattern of Ca~V~ β subunits varies across brain tissue and within a single cell type during the development ([@bib48]; [@bib50]). This implies that regulation of N-type channels in nerve might change with developmental stage.

In conclusion, our study provides some insight into the possible mechanism of how G~q~PCRs modulate the Ca^2+^ channel activity and thus regulate intracellular Ca^2+^ concentrations in excitable nerve terminals and tissues ([@bib33]). Our results showed that G~q/11~PCRs can inhibit Ca~V~2.2 channels through the Gβγ-mediated, voltage-dependent pathway and the PIP~2~-sensitive, voltage-independent pathway and that this dual mode of inhibition after G~q~PCR activation is tightly controlled by the type of Ca~V~ β subunit present. Considering the previous observations that Ca~V~ channels can be regulated by diverse intracellular signals, such as protein kinase C and SNARE proteins ([@bib45]; [@bib53]; [@bib19]; [@bib36]), our data provide further intricacy in the G protein modulatory mechanism of Ca^2+^ influx and therefore neurotransmitter release in the synaptic terminal.
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